T cell receptor beta chain (TCR-Vβ) repertoire of circulating CD4+CD25−, CD4+CD25lowand CD4+CD25highT cells in patients with long-term renal allograft survival
Authors:
- Luis F. GarcãaLGLuis F. Garcãa
- 1 January 2010
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 23 (1) , 54-63
Abstract
The mechanisms underlying maintenance of renal allografts in humans under minimal or conventional immunosuppression are poorly understood. There is evidence that CD4(+) CD25(+) regulatory T cells and clonal deletion, among other mechanisms of tolerance, could play a key role in clinical allograft survival. Twenty-four TCR-Vbeta families were assessed in CD4(+) CD25(-), CD4(+) CD25(low) and CD4(+) CD25(high) T cells from patients with long-term renal allograft survival (LTS), patients exhibiting chronic rejection (ChrRx), patients on dialysis (Dial) and healthy controls (HC) by flow cytometry. LTS patients presented a higher variability in their TCR-Vbeta repertoire, such decreased percentage of Vbeta2(+), Vbeta8a(+) and Vbeta13(+) in CD4(+) CD25(low) and (high) compared with CD4(+) CD25(-) subset and increased Vbeta4 and Vbeta7 families in CD4(+) CD25(high) T cells exclusively. Additionally, LTS patients, particularly those that were not receiving calcineurin inhibitors (CNI), had increased percentages of CD4(+) CD25(high) T cells when compared with Dial (P < 0.05) and ChrRx (P < 0.05) patients. Our results suggest that a differential expression of particular TCR-Vbeta families and high levels of circulating CD4(+) CD25(high) T cells in long-term surviving renal transplant patients could contribute to an active and specific state of immunologic suppression. However, the increase in this T cell subset with regulatory phenotype can be affected by CNI.Keywords
This publication has 56 references indexed in Scilit:
- Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor‐directed responses after transplantationClinical Transplantation, 2008
- CD4+ CD25bright+ Regulatory T Cells Can Mediate Donor Nonreactivity in Long-Term Immunosuppressed Kidney Allograft PatientsAmerican Journal of Transplantation, 2006
- Ex vivo expansion of human CD4+CD25high regulatory T cells from transplant recipients permits functional analysis of small blood samplesJournal of Immunological Methods, 2006
- Promotion of Allograft Survival by CD4+CD25+ Regulatory T Cells: Evidence for In Vivo Inhibition of Effector Cell ProliferationThe Journal of Immunology, 2004
- Regulatory CD25+ T Cells in Human Kidney Transplant RecipientsJournal of the American Society of Nephrology, 2003
- CD4+CD25+ Regulatory T Cells Do Not Significantly Contribute to Direct Pathway Hyporesponsiveness in Stable Renal Transplant PatientsJournal of the American Society of Nephrology, 2003
- Identification of Regulatory T Cells in Tolerated AllograftsJournal of Experimental Medicine, 2002
- Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory CellsThe Journal of Immunology, 2001
- Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory BlockadeJournal of Experimental Medicine, 2001
- CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 ProductionJournal of Experimental Medicine, 1998